Editorial: Beta-Cell Fate: From Gene Circuits to Disease Mechanisms

Luiza Ghila; Kenichiro Furuyama; Shane T Grey; Hanne Scholz; Simona Chera

doi:10.3389/fgene.2022.822440

Editorial: Beta-Cell Fate: From Gene Circuits to Disease Mechanisms

Front Genet. 2022 Feb 25:13:822440. doi: 10.3389/fgene.2022.822440. eCollection 2022.

Authors

Luiza Ghila¹, Kenichiro Furuyama², Shane T Grey^{3

4}, Hanne Scholz^{5

6}, Simona Chera¹

Affiliations

¹ Center for Diabetes Research, Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.
² Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
³ Immunology Department, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
⁴ Faculty of Medicine, St Vincent's Clinical School, University of New South Wales Sydney, Sydney, NSW, Australia.
⁵ Hybrid Technology Hub-Centre of Excellence, Faculty of Medicine, University of Oslo, Oslo, Norway.
⁶ Department of Transplant Medicine and Institute for Surgical Research, Oslo University Hospital, Oslo, Norway.

No abstract available

Keywords: MODY (mature onset diabetes of the young); T1D (type 1 diabetes); T2D (type 2 diabetes); UPR stress; cell reprogramming; islet heterogeneity; mRNA processing.

Publication types

Editorial